fashion -WSS

fashion

author：Wikipedia 2025-09-05 13:44:07 - browse：68

A follow-up study of a first-of-its-kind cancer treatment may reflect systemic biases, the Food and Drug Administration said ahead of an advisory committee meeting Thursday to determine whether the drug should remain on the market.

The treatment, Lumakras, is designed to treat lung cancer caused by a specific genetic mutation to a protein called KRAS. It’s one of the most common genetic mutations in cancer, but repeated clinical trial failures had led researchers to deem it “undruggable” until a glimmer of hope came about a decade ago.

Lumakras received an accelerated, or conditional, approval in May 2021, making it the first KRAS drug on the market. Now, the drug’s manufacturer, Amgen, needs to prove it works.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Abbott's new heart device gets FDA advisory panel nod

hotspot

explore

WSS

Study: Spinal cord stimulation helps patients with paralysis walk again

As obesity drug market grows, telehealth companies court payers

Why Eli Lilly’s earnings didn’t quite live up to the hype

Readout Newsletter: Amylyx, Aurinia, and IQVIA

California store owner shot dead in dispute over displaying Pride flag: Police

Websites selling Wegovy, Zepbound ingredients targeted by FDA

knowledge

fashion

hotspot

Bright Health sells Medicare Advantage business to Molina

Hospital at home shows how to bring innovation to health care

How to save PrEP access — and even expand it

Wegovy improves function in certain heart failure patients

Cancer drug shortages should be causing more outrage

Readout Newsletter: Amylyx, Aurinia, and IQVIA

Medical leaders decry Supreme Court decision on affirmative action

As obesity drug market grows, telehealth companies court payers

Trump demands the U.S. pay no more for drugs than other countries … again

Tome Biosciences co

hotspot

AMAs digital advisors table RPM coding reform proposal, again

FDA greenlights medical device to combat bladder issues

FDA advisory panel to debate high blood pressure devices

Abortion policy in the spotlight at Republican debate

People can get long Covid without testing positive for virus: Study

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

hotspot

entertainment

explore

focus